Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;66(1):163-5.
doi: 10.1590/s1807-59322011000100028.

IDH1 mutations in a Brazilian series of Glioblastoma

Affiliations

IDH1 mutations in a Brazilian series of Glioblastoma

Miyuki Uno et al. Clinics (Sao Paulo). 2011.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival of glioblastoma patients according to their IDH1 mutation status (positive vs. negative). Glioblastoma patients carrying an IDH1 mutation had longer overall survival (log‐rank test; Mantel–Cox test; p = 0.075).

References

    1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. 10.1007/s00401‐007‐0243‐4 - DOI - PMC - PubMed
    1. von Deimling A, Louis DN, Schramm J, Wiestler OD. Astrocytic gliomas: characterization on a molecular genetic basis. Recent Results Cancer Res. 1994:33–42. - PubMed
    1. Korshunov A, Sycheva R, Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age <50 years. Cancer. 2005;104:825–32. 10.1002/cncr.21221 - DOI - PubMed
    1. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008;116:597–602. 10.1007/s00401‐008‐0455‐2 - DOI - PubMed
    1. Ichimura K, Pearson DM, Kocialkowski S, Bäcklund LM, Chan R, Jones DT, et al. IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas. Neurol Oncol. 2009;11:341–7. 10.1215/15228517‐2009‐025 - DOI - PMC - PubMed

Publication types

Substances